BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1438411)

  • 1. Neuroblastoma purging by immunorosette depletion.
    Slaper-Cortenbach IC; de Vries-van Rossen A; Huijbens RJ; van Leeuwen EF; Figdor CG
    Prog Clin Biol Res; 1992; 377():147-62. PubMed ID: 1438411
    [No Abstract]   [Full Text] [Related]  

  • 2. Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma.
    Skala JP; Rogers PC; Chan KW; Chao HY; Rodriguez WC
    Prog Clin Biol Res; 1992; 377():71-8. PubMed ID: 1438447
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow purging with antisense oligodeoxynucleotides.
    Gewirtz AM
    Prog Clin Biol Res; 1992; 377():215-24; discussion 225-6. PubMed ID: 1438418
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of purging clonogenic leukemia cells using ether lipid and hyperthermia for autologous bone marrow transplantation.
    Min WS; Park HM; Han CH; Park JW; Kim CC; Kim DJ
    Prog Clin Biol Res; 1992; 377():87-95. PubMed ID: 1438449
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
    Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
    Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Ethiofos on cytotoxicity of pharmacological purging protocols used for autologous marrow grafts in acute lymphoblastic leukemia.
    Skala JP; Rogers PC; Chan KW; Rodriguez WC
    Prog Clin Biol Res; 1992; 377():57-62. PubMed ID: 1332075
    [No Abstract]   [Full Text] [Related]  

  • 7. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
    Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
    Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of Ilmofosine on acute lymphoblastic leukemia cells and on normal hemopoietic cells.
    Skala JP; Rogers PC; Chan KW; Khangura SS; Rodriguez WC
    Prog Clin Biol Res; 1992; 377():63-9. PubMed ID: 1438445
    [No Abstract]   [Full Text] [Related]  

  • 9. Purging of acute lymphoblastic leukemia by long-term marrow culture.
    Douay L; Ozsahin H; Barbu V; Fabrega S; Giarratana MC; Da WM; Allieri A; Gorin NC
    Prog Clin Biol Res; 1992; 377():205-13; discussion 214. PubMed ID: 1438417
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts.
    Vervoordeldonk SF; Merle PA; Steenbergen EJ; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC
    Prog Clin Biol Res; 1994; 389():601-9. PubMed ID: 7700926
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunomagnetic purging in autologous bone marrow transplantation: experience in fourteen patients.
    Canals C; Puntí C; Picón M; Amill B; Tugues D; Sanchez T; Badell I; Pardo N; Ortega J; Vivancos P
    Prog Clin Biol Res; 1992; 377():289-96. PubMed ID: 1438427
    [No Abstract]   [Full Text] [Related]  

  • 12. Large-scale immunomagnetic separation system for the removal of tumor cells from bone marrow.
    Gee A; Moss T; Mansour V; Kulcinski D; Law P; Ishizawa L; Hardwick A
    Prog Clin Biol Res; 1992; 377():181-7. PubMed ID: 1438414
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow.
    Cashman JD; Eaves AC; Wolpe S; Eaves CJ
    Prog Clin Biol Res; 1994; 389():261-8. PubMed ID: 7700910
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of mafosfamide on the clonogenic cells in precursor B acute lymphoblastic leukemia: significance for ex vivo purging of bone marrow.
    Kramer B; Makrynikola V; Bradstock K
    Prog Clin Biol Res; 1992; 377():41-7. PubMed ID: 1438438
    [No Abstract]   [Full Text] [Related]  

  • 15. Purging with 4-hydroperoxycyclophosphamide combinations.
    Jones RJ; Miller CB; Rowley SD
    Prog Clin Biol Res; 1992; 377():1-9; discussion 10-1. PubMed ID: 1438406
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow purging in patients with refractory cancer.
    Meagher RC; Stevens DA; Herzig GP; Fay JW; Harden EA; Montes VM; Heye MM; Herzig RH
    Prog Clin Biol Res; 1992; 377():281-7. PubMed ID: 1438426
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
    Gidáli J; Fehér I
    Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of single and double immunomagnetic depletion on the hemopoietic capacity of marrow in patients with advanced neuroblastoma submitted to autologous bone marrow transplantation.
    Lopez M; Zucker JM; Urresola R; Douay L; Quintana E; Kemshead J; Gorin NC; Vilcoq JR
    Bone Marrow Transplant; 1987 Dec; 2(4):413-9. PubMed ID: 3332188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
    Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
    Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation. Separation of stem cells.
    Viktora L; Hermanová E; Herzog P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):435-42. PubMed ID: 6182063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.